BETA BIONICS INC.
Manufacturer adverse-event records for BETA BIONICS INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2024–2026 · heavy-book · quiet Death-code · balanced
Volume signature
BETA BIONICS INC. sits in the heavy MAUDE book
BETA BIONICS INC. accounts for 37,341 FDA MAUDE reports (#100 of 434, heavy-book tercile). Death-coded event_type share is 0.03% (quiet); Injury share 17.9% (balanced).
What the volume reading shows for BETA BIONICS INC.
The standout signal for BETA BIONICS INC. is filing volume: 37,341 adverse-event reports in FDA MAUDE (#100 of 434, heavy-book). Death-coded event_type share sits at 0.03% (quiet).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BETA BIONICS INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 2 device types, led in this extract by Malfunction at 30,657 (82.1% of event_type total). Peak single-year volume reaches 24,642 reports across 3 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (2)
| Device | Reports |
|---|---|
| Alternate Controller Enabled Insulin Infusion Pump | 36,597 |
| Set, Administration, Intravascular | 744 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.